Pneumococcal Serotypes and Mortality following Invasive Pneumococcal Disease: A Population-Based Cohort Study-Reference-Cited by-同舟云学术

Pneumococcal Serotypes and Mortality following Invasive Pneumococcal Disease: A Population-Based Cohort Study

Published:2009-05-26 Issue:5 Volume:6 Page:e1000081
ISSN:1549-1676
Container-title:PLoS Medicine
language:en
Short-container-title:PLoS Med

Author:

Harboe Zitta B.,Thomsen Reimar W.,Riis Anders,Valentiner-Branth Palle,Christensen Jens Jørgen,Lambertsen Lotte,Krogfelt Karen A.,Konradsen Helle B.,Benfield Thomas L.

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference48 articles.

1. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper.;[No authors listed];Wkly Epidemiol Rec,2007

2. WHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries, 26–27 October 2006, Geneva.;T Cherian;Vaccine,2007

3. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis.;A Sinha;Lancet,2007

4. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004.;LA Hicks;J Infect Dis,2007

5. Serotype replacement in invasive pneumococcal disease: where do we go from here?;WP Hanage;J Infect Dis,2007

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular genetic characteristics of Streptococcus pneumoniae serogroups 15 and 11 representatives circulating in Russia and their relationship with global genetic lineages;Journal of microbiology, epidemiology and immunobiology;2024-09-10

2. Synthetic BSA-conjugated disaccharide related to the Streptococcus pneumoniae serotype 3 capsular polysaccharide increases IL-17A Levels, γδ T cells, and B1 cells in mice;Frontiers in Immunology;2024-05-22

3. Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13;Journal of Medical Economics;2024-04-19

4. A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years and older;Vaccine;2024-04

5. A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants;International Journal of Infectious Diseases;2024-04